<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120">By contrast, MERS begins with pyrexia, cough, pharyngitis, muscle aches, and joints pain, succeeded by dyspnoea, and fast progress to pneumonia in 7Â days, frequently warrants ventilatory assistance 
 <xref rid="b0210" ref-type="bibr">[42]</xref>. Abnormal chest X-rays are more prevalent than in SARS cases, with up to 89% of cases requiring ICU care, unlike SARS, the clinical pattern of MERS is more severe in immunocompromised cases and regularly mild in patients with no comorbidities 
 <xref rid="b0070" ref-type="bibr">[14]</xref>, 
 <xref rid="b0215" ref-type="bibr">[43]</xref>. Additionally, up to 72% of MERS patients likely to manifest with comorbidities 
 <xref rid="b0220" ref-type="bibr">[44]</xref>. Correspondingly, RT-PCR is warranted for MERS-CoV confirmation and ruling out differentials like H1N1 and Influenza A and B 
 <xref rid="b0180" ref-type="bibr">[36]</xref>, 
 <xref rid="b0225" ref-type="bibr">[45]</xref>.
</p>
